Sharechat Logo

Tower fails to sell Trustee business

By NZPA

Friday 15th November 2002

Text too small?
Embattled fund manager and insurer, Tower Ltd, said today it had failed to sell its Tower Trust in Australia and New Zealand.

Tower said it had taken the personal and corporate trustee business off the market.

The sale, announced in July, was being managed by Sydney- based KPMG Corporate Finance. Tower had planned to retain Tower Trust's superannuation and investment management services.

"A number of interested parties have completed due diligence and submitted bids for the business in recent months, but Tower has decided that retaining this business, and incorporating it in Tower's growth strategies going forward, would be the best use of shareholder capital," the company said in a statement.

It said Tower Trust was a profitable and growing business and it would continue to be an important contributor to Tower.

Tower said recent changes in its management and structure, the announcement of a loss for the 2002 financial year, together with this decision not to sell Tower Trust, "make it appropriate for Tower to review some of the strategic and operational initiatives it has been progressing".

It said it would announce the review findings early next year.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy